Additionally, TGFβ promotes immune escape and drug resistance in MM by suppressing the expression of natural killer (NK) cell activation receptors (e.g., NKG2D) and their effector functions (e.g., degranulation). Here, KLRK1 is linked to Miyoshi myopathy.